v3.26.1
Condensed Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
ATM Offering
Public offering
Common Stock
Common Stock
ATM Offering
Common Stock
Public offering
Additional Paid-in Capital
Additional Paid-in Capital
ATM Offering
Additional Paid-in Capital
Public offering
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2024       212,210,597              
Beginning balance at Dec. 31, 2024 $ 422,179     $ 212     $ 2,241,879     $ (1,819,823) $ (89)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon vesting of RSUs (in shares)       2,158,522              
Issuance of common stock upon vesting of RSUs 0     $ 2     (2)        
Issuance of common stock, net of commissions and offering costs (in shares)         3,842,282            
Issuance of common stock, net of commissions and offering costs   $ 10,002     $ 4     $ 9,998      
Stock-based compensation 12,175           12,175        
Employee stock purchase plan (in shares)       386,861              
Employee stock purchase plan 638     $ 1     637        
Net loss (59,733)                 (59,733)  
Net unrealized (loss) gain on available-for-sale investments 132                   132
Ending balance (in shares) at Mar. 31, 2025       218,598,262              
Ending balance at Mar. 31, 2025 385,393     $ 219     2,264,687     (1,879,556) 43
Beginning balance (in shares) at Dec. 31, 2024       212,210,597              
Beginning balance at Dec. 31, 2024 422,179     $ 212     2,241,879     (1,819,823) (89)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (110,676)                    
Net unrealized (loss) gain on available-for-sale investments 44                    
Ending balance (in shares) at Jun. 30, 2025       220,133,876              
Ending balance at Jun. 30, 2025 344,561     $ 220     2,274,885     (1,930,499) (45)
Beginning balance (in shares) at Mar. 31, 2025       218,598,262              
Beginning balance at Mar. 31, 2025 385,393     $ 219     2,264,687     (1,879,556) 43
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon vesting of RSUs (in shares)       398,743              
Issuance of common stock upon vesting of RSUs 0     $ 0     0        
Issuance of common stock, net of commissions and offering costs (in shares)         1,136,871            
Issuance of common stock, net of commissions and offering costs   1,514     $ 1     1,513      
Stock-based compensation 8,685           8,685        
Net loss (50,943)                 (50,943)  
Net unrealized (loss) gain on available-for-sale investments (88)                   (88)
Ending balance (in shares) at Jun. 30, 2025       220,133,876              
Ending balance at Jun. 30, 2025 $ 344,561     $ 220     2,274,885     (1,930,499) (45)
Beginning balance (in shares) at Dec. 31, 2025 229,413,523     229,413,523              
Beginning balance at Dec. 31, 2025 $ 292,542     $ 229     2,302,753     (2,010,709) 269
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options and vesting of RSUs (in shares)       2,476,547              
Issuance of common stock upon exercise of stock options and vesting of RSUs 4     $ 2     2        
Issuance of common stock, net of commissions and offering costs (in shares)         12,476,533            
Issuance of common stock, net of commissions and offering costs   $ 20,668     $ 13     $ 20,655      
Stock-based compensation 8,270           8,270        
Employee stock purchase plan (in shares)       449,810              
Employee stock purchase plan 450     $ 1     449        
Net loss (42,607)                 (42,607)  
Net unrealized (loss) gain on available-for-sale investments (452)                   (452)
Ending balance (in shares) at Mar. 31, 2026       244,816,413              
Ending balance at Mar. 31, 2026 $ 278,875     $ 245     2,332,129     (2,053,316) (183)
Beginning balance (in shares) at Dec. 31, 2025 229,413,523     229,413,523              
Beginning balance at Dec. 31, 2025 $ 292,542     $ 229     2,302,753     (2,010,709) 269
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (85,284)                    
Net unrealized (loss) gain on available-for-sale investments $ (787)                    
Ending balance (in shares) at Jun. 30, 2026 345,345,427     345,345,427              
Ending balance at Jun. 30, 2026 $ 436,175     $ 345     2,532,341     (2,095,993) (518)
Beginning balance (in shares) at Mar. 31, 2026       244,816,413              
Beginning balance at Mar. 31, 2026 278,875     $ 245     2,332,129     (2,053,316) (183)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon vesting of RSUs (in shares)       329,014              
Issuance of common stock, net of commissions and offering costs (in shares)           100,200,000          
Issuance of common stock, net of commissions and offering costs     $ 187,872     $ 100     $ 187,772    
Stock-based compensation 12,440           12,440        
Net loss (42,677)                 (42,677)  
Net unrealized (loss) gain on available-for-sale investments $ (335)                   (335)
Ending balance (in shares) at Jun. 30, 2026 345,345,427     345,345,427              
Ending balance at Jun. 30, 2026 $ 436,175     $ 345     $ 2,532,341     $ (2,095,993) $ (518)